Lectin Array-Based Strategies for Identifying Metastasis-Associated Changes in Glycosylation
Since 2005, lectin microarray technology has emerged as a relatively simple yet powerful technique for the comprehensive analysis of glycoprotein glycosylation. Lectin microarrays represent a new analytical method that can be used to explore the human glycome, a unique source of markers of diseases including cancer. The lectin microarray technology is a sensitive tool with the potential to allow high-throughput analysis of cancer-associated changes in glycosylation. This chapter describes the generation of a lectin-binding signature associated with metastatic primary breast tumours that have been resected, fixed, and embedded in paraffin. Procedures concerning sample and lectin microarray preparation are explained, alongside experimental considerations and approaches to data analysis.
- Anti-HMdU Autoantibodies in Human Sera as a Biomarker of Cancer Risk
- T-Cell Receptor Clonotype Mapping Using Denaturing Gradient Gel Electrophoresis: Analysis of Clonal T-Cell Responses in Melanoma
- Marker Utility for Combination Therapy
- Electrophoretic Mobility Shift Analysis of the DNA Binding of Tumor Suppressor Gene Products
- Alterations in Oncogenes, Tumor Suppressor Genes, and Growth Factors Associated with Epithelial Ovarian Cancers
- Chromosomal Copy Number Analysis in Melanoma Diagnostics
- 人肝癌细胞与抑癌基因的关系
- pIRES2-eGFP转染细胞的经验
- G418筛选实验相关问题
- 如何得到稳定转染的克隆